FDA approvals outrun staff cuts: 23 novel drugs mark the best first half in three years – Endpoints News
FDA approvals outrun staff cuts: 23 novel drugs mark the best first half in three years Endpoints NewsFDA Approvals…
FDA Commissioner Makary defends agency’s decision on Replimune’s drug
May 5 (Reuters) – U.S. Food and Drug Administration Commissioner Dr. Marty Makary on Tuesday defended the agency’s…
FDA: Three psychedelic drugs to get review following Trump directive
WASHINGTON (AP) — The Food and Drug Administration said Friday it will offer ultra-fast review to three psychedelic…
Top FDA official seeks to hire friend pushing new antidepressants warning
WASHINGTON (AP) — The Food and Drug Administration’s top drug regulator, Dr. Tracy Beth Hoeg, is working to…
FDA to offer bonus payments to staffers who complete speedy drug reviews
WASHINGTON (AP) — The head of the Food and Drug Administration plans to start offering bonus payments to…
FDA plans bonuses to staffers who complete speedy drug reviews
WASHINGTON (AP) — The head of the Food and Drug Administration plans to start offering bonus payments to…
FDA will drop two-study requirement for new drug approvals, aiming to speed access
WASHINGTON (AP) — The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous…
FDA will drop two-study requirement for new drug approvals, aiming to speed access
WASHINGTON (AP) — The Food and Drug Administration plans to drop its longtime standard of requiring two rigorous…
More drugs should be over-the-counter
Food and Drug Administration Commissioner Marty Makary told CNBC that he believes “everything should be over the counter”…
Takeaways on turmoil surrounding FDA fast-track drug program
WASHINGTON (AP) — A plan to slash drug review times at the Food and Drug Administration is sparking…
FDA commissioner’s drug review plan sparks alarm
WASHINGTON (AP) — The Food and Drug Administration commissioner’s effort to drastically shorten the review of drugs favored…
Rick Pazdur to replace George Tidmarsh at FDA drug center
WASHINGTON (AP) — The Food and Drug Administration on Tuesday named a longtime regulator of cancer medicines to…